学会速報レポート

2019 Annual Meeting of the American Society of Clinical Oncology®

海外学会などで発表されたホットでタイムリーな演題を専門医が厳選。レポートとコメントを掲載します。

2019年5月31日~6月4日にシカゴで開催された、2019 Annual Meeting of the American Society of Clinical Oncology®より、消化器癌を中心とした注目演題のレポートを掲載しています。

ASCO2019 FLASH REPORT - Abstract 4010 -

Abstract 4010:Shah MA, et al.
Pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer: Phase 3 KEYNOTE-181 study.

ASCO2019 FLASH REPORT - Abstract LBA4007 -

Abstract LBA4007:Tabernero J, et al
Pembrolizumab with or without chemotherapy versus chemotherapy for advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The phase III KEYNOTE-062 study.

ASCO2019 FLASH REPORT- Abstract #2522 -

Regorafenib plus nivolumab in patients with advanced gastric (GC) or colorectal cancer (CRC): An open-label, dose-finding, and dose-expansion phase 1b trial (REGONIVO, EPOC1603).

ASCO2019 FLASH REPORT - Abstract #3501 -

Prospective pooled analysis of four randomized trials investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months {m}) for patients (pts) with high-risk stage II colorectal cancer (CC).

ASCO2019 FLASH REPORT - Abstract 4002 -

Abstract4002:I Namiki, et al.
A multicenter randomized controlled trial to evaluate the efficacy of surgery vs. radiofrequency ablation for small hepatocellular carcinoma (SURF trial).

ASCO2019 FLASH REPORT - Abstract LBA -

Abstract LBA:Kindler, H L,, et al.
Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial.